Preoperative Epoetin Alfa vs Autologous Blood Donation in Primary Total Knee Arthroplasty

Journal of Arthroplasty

Volumn 21, Issue 5, 2006, Pages 628-635

  Deutsch, Allen ^a   Spaulding, Janice ^b   Marcus, Randall E ^c  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b TAMPA GENERAL HOSPITAL   (United States)

^c UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

allogeneic blood; autologous blood; epoetin alfa; knee arthroplasty; surgery

Indexed keywords

HEMOGLOBIN; PLACEBO; RECOMBINANT ERYTHROPOIETIN;

ADULT; AGED; ANEMIA; ARTICLE; BLEEDING; BLOOD AUTOTRANSFUSION; BLOOD TRANSFUSION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG SAFETY; FATIGUE; FEMALE; HEMATOCRIT; HEMATOLOGICAL PARAMETERS; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPOTENSION; INCIDENCE; MALE; MICTURITION DISORDER; OPEN STUDY; PARALLEL DESIGN; PERIOPERATIVE PERIOD; PREOPERATIVE CARE; RANDOMIZED CONTROLLED TRIAL; RETICULOCYTE COUNT; TOTAL KNEE REPLACEMENT; URINE VOLUME;

AGED; AGED, 80 AND OVER; ARTHROPLASTY, REPLACEMENT, KNEE; BLOOD LOSS, SURGICAL; BLOOD TRANSFUSION, AUTOLOGOUS; EPOETIN ALFA; FEMALE; HEMATINICS; HUMANS; MALE; MIDDLE AGED; PREOPERATIVE CARE; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 33746697137     PISSN: 08835403     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arth.2005.12.002     Document Type: Article

References (35)

1. Earnshaw P. Blood conservation in orthopaedic surgery: the role of epoetin alfa. Int Orthop 25 (2001) 273
2. Fergusson D., Blair A., Henry D., et al. Technologies to minimize blood transfusion in cardiac and orthopedic surgery. Int J Technol Assess Health Care 15 (1999) 717
3. Goldberg M.A. Perioperative epoetin alfa increases red blood cell mass and reduces exposure to transfusion: results of randomized clinical trials. Semin Hematol 34 2 Suppl (1997) 41
4. Henry D.A., Carless P.A., Moxey A.J., et al. Preoperative autologous donation for minimizing perioperative allogeneic blood transfusion. (Cochrane Review). The Cochrane Library. Issue 4 (2003), John Wiley & Sons, Ltd., Chichester (UK)
5. Stowell C.P., Chandler H., Jove M., et al. An open-label, randomized study to compare the safety and efficacy of perioperative epoetin alfa with preoperative autologous blood donation in total joint arthroplasty. Orthopedics 22 Suppl (1999) s105
6. Popovsky M.A., Whitaker B., and Arnold N.L. Severe outcomes of allogeneic and autologous blood donation: frequency and characterization. Transfusion 35 (1995) 734
7. Goodnough L.T., and Monk T.G. Evolving concepts in autologous blood procurement and transfusion: case reports of perisurgical anemia complicated by myocardial infarction. Am J Med 101 (1996) 33
8. National Heart, Lung, and Blood Institute Expert Panel on the Use of Autologous Blood. Transfusion alert: use of autologous blood. Transfusion 35 (1995) 703
9. Billote D.B., Glisson S.N., Green D., et al. A prospective, randomized study of preoperative autologous donation for hip replacement surgery. J Bone Joint Surg 84-A (2002) 1299
10. Savoia H.F., Metz J., Maxwell E.L., et al. Utilization of preoperative autologous blood donation in elective surgery. ANZ J Surg 72 (2002) 557
11. Groh G.I., Buchert P.K., and Allen W.C. A comparison of transfusion requirements after total knee arthroplasty using the Solcotrans autotransfusion system. J Arthroplasty 5 (1990) 281
12. Han C.-D., and Shin D.-E. Postoperative blood salvage and reinfusion after total joint arthroplasty. J Arthroplasty 12 (1997) 511
13. Martin J.W., Whiteside L.A., Milliano M.T., et al. Postoperative blood retrieval and transfusion in cementless total knee arthroplasty. J Arthroplasty 7 (1992) 205
14. Woolsen S.T., and Wall W.W. Autologous blood transfusion after total knee arthroplasty. J Arthroplasty 18 (2003) 243
15. Billote D.B., Abdoue A.G., and Wixson R.L. Comparison of acute normovolemic hemodilution and preoperative autologous blood donation in clinical practice. J Clin Anesth 12 (2000) 31
16. Goodnough L.T., Despotis G.J., Merkel K., et al. A randomized trial comparing acute normovolemic hemodilution and preoperative autologous blood donation in total hip arthroplasty. Transfusion 40 (2000) 1054
17. Schmied H., Schiferer A., Sessler D.I., et al. The effects of red-cell scavenging, hemodilution, and active warming on allogenic blood requirements in patients undergoing hip or knee arthroplasty. Anesth Analg 86 (1998) 387
18. Borghi B., and Casati A. Incidence and risk factors for allogenic blood transfusion during major joint replacement using an integrated autotransfusion regimen. Rizzoli Study Group on Orthopaedic Anaesthesia. Eur J Anaesthesiol 17 (2000) 411
19. Faris P.M., Spence R.K., Larholt K.M., et al. The predictive power of baseline hemoglobin for transfusion in surgery patients. Orthopedics 22 1 Suppl (1999) s135
20. Procrit (epoetin alfa) prescribing information (2005), Ortho Biotech Products, L.P., Raritan (NJ)
21. Faris P.M., and Ritter M.A. Epoetin alfa. A bloodless approach for the treatment of perioperative anemia. Clin Orthop Relat Res 357 (1998) 60
22. American Association of Blood Banks. All about blood. Facts about blood and blood banking. Available at:. http://www.aabb.org/All_About_Blood/FAQs/aabb_faqs.htm [Accessed August 11, 2005]
23. de Andrade J.R., Jove M., Landon G., et al. Baseline hemoglobin as a predictor of risk of transfusion and response to epoetin alfa in orthopedic surgery patients. Am J Orthop 25 (1996) 533
24. Faris P.M., Ritter M.A., and Abels R.I. The effects of recombinant human erythropoietin on perioperative transfusion requirements in patients having a major orthopaedic operation. The American Erythropoietin Study Group. J Bone Joint Surg 78 (1996) 62
25. Goldman M., Rémy-Prince S., Trépanier A., et al. Autologous donation error rates in Canada. Transfusion 37 (1997) 523
26. Bierbaum B.E., Callaghan J.J., Galante J.O., et al. An analysis of blood management in patients having a total hip or knee arthroplasty. J Bone Joint Surg 81 (1999) 2
27. Hardwick M.E., Morris B.M., and Colwell Jr. C.W. Two-dose epoetin alfa reduces blood transfusions compared with autologous donation. Clin Orthop Relat Res 423 (2004) 240
28. Canadian Orthopedic Perioperative Erythropoietin Study Group. Effectiveness of perioperative recombinant human erythropoietin in elective hip replacement. Lancet 341 (1993) 1227
29. Cushner F.D., Locker J.R., Hanssen A.D., et al. Use of recombinant human erythropoietin in two-stage total knee arthroplasty for infection. Clin Orthop Related Res 392 (2001) 116
30. Goldberg M.A., McCutchen J.W., Jove M., et al. A safety and efficacy comparison study of two dosing regimens of epoetin alfa in patients undergoing major orthopedic surgery. Am J Orthop 25 (1996) 544
31. Lofthouse R.A., Boitano M.A., Davis J.R., et al. Preoperative administration of epoetin alfa to reduce transfusion requirements in elderly patients having primary total hip or knee reconstruction. J South Orthop Assoc 9 (2000) 175
32. Gombotz H., Gries M., Sipurzynski S., et al. Preoperative treatment with recombinant human erythropoietin or predeposit of autologous blood in women undergoing primary hip replacement. Acta Anaesthesiol Scand 44 (2000) 737
33. Keating E.M., Ranawat C.S., and Cats-Baril W. Assessment of postoperative vigor in patients undergoing elective total joint arthroplasty: a concise patient- and caregiver-based instrument. Orthopedics 22 Suppl 1 (1999) S119
34. Lawrence V.A., Silverstein J.H., Cornell J.E., et al. Higher Hb level is associated with better early functional recovery after hip fracture repair. Transfusion 43 (2003) 1717
35. Carson J.L., Duff A., Poses R.M., et al. Effect of anaemia and cardiovascular disease on surgical mortality and morbidity. Lancet 348 (1996) 1055